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INTRACELLULAR adhesion molecule-1 (ICAM-1)-mediated
cellÐcell  adhesion  is  thought  to  play  an  important
role  at  sites  of  inflammation.  Recent  evidence  sug-
gests  that  ICAM-1  surface  expression  on  alveolar
macrophages is increased in pulmonary sarcoidosis
and that inflammatory granuloma formation is char-
acterized  by  the  aggregation  of  macrophages.  The
present  study  shows that  ICAM-1 expression is  sig-
nificantly  elevated  on  alveolar  macrophages  from
patients with sarcoidosis in response to tumor necro-
sis  factor-a (TNF-a )  and  interferon-g (INF-g )  com-
pared with healthy controls. Aggregation and adhe-
sion  were  significantly  increased  in  alveolar
macrophages  treated  with  TNF-a and  INF-g ,  and
significantly  inhibited  in  those  pretreated  with  a
monoclonal antibody to  ICAM-1. Similarly,  aggrega-
tion  and  adhesion  were  inhibited  in  macrophages
treated  with  heparin,  which  then  exhibited  a  wide
range  of  biological  activities  relevant  to  inflamma-
tion. These results suggested that the surface expres-
sion of ICAM-1 on alveolar macrophages in response
to TNF-a and INF-g is important in mediating aggrega-
tion  and  adhesion.  Additionally,  heparin  may  be
useful  for  developing  novel  therapeutic  agents  for
fibrotic lung disease.
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Introduction
Cell adhesion is an important event that plays a role in
cell-to-cell communication mediated by inflammatory
cytokines  and  adhesion  molecules.  Several  chronic
interstitial  lung  diseases,  such  as  sarcoidosis  and
hypersensitivity  pneumonitis,  are  characterized  by
interstitial cellular infiltration or alveolitis, granuloma
and varying degrees of interstitial fibrosis.1–3
Granuloma  is  characterized  as  masses  of  macro-
phages, lymphocytes and epitheloid cells. At inflam-
matory  sites,  macrophages  that  can  release  many
mediators, such as tumor necrosis factor-a (TNF-a),
interleukin-1b,  interferon-g (IFN-g),  platelet-derived
growth factor and others,4–6 interact between various
cell  types.  Both  TNF-a and  intracellular  adhesion
molecule-1 (ICAM-1) participate in lymphocyte activa-
tion and granuloma formation,7,8 suggesting that one
mechanism of TNF-a in granuloma develops through
TNF-a-induced  ICAM-1  expression  in  schistosome
granulation.9 Aggregation of rat alveolar macrophages
is induced by TNF-a during the upregulation of ICAM-
1  expression  on  alveolar  macrophages.5,8,10 He-
parin, a major component of the mast cell granule
matrix, is a polyanionic anticoagulant. Apart from this
classical  role,  heparin  and  heparin-related complex
have  numerous  other  functions,  among  which  are
inhibition of fibrin deposition in tissues, proliferation
of  fibroblasts  associated  with  proteases  including
tryptase  and  chymase,  and  regulation  of  T-cell  or
eosinophil  infiltration-mediated  allergic  inflamma-
tion.11–16 However, little evidence shows that heparin
attenuates  cell–cell  interactions  with  adhesion
molecules.
The present study investigates the roles of TNF-a
and INF-g on ICAM-1 expression of human alveolar
macrophages, aggregation formation and the effect of
heparin  on  aggregation  of  human  alveolar
macrophages.
Material and methods
Study population
Six  patients  with  pulmonary  sarcoidosis (four  men
and two women; mean age, 33 years) participated in
the  study.  The  diagnosis  was  based  on  consistent
clinical features, along with biopsy evidence of non-
caseating  epithelioid  cell  granulation.  Six  control
patients had no evidence of interstitial lung disease
(five  men  and  one  woman). All  were  non-smokers
undergoing  routine  bronchoscopy  for  suspected
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normal  and  bronchoalveolar  lavage  (BAL)  cytology
showed normal differential cell counts.
The  study  was  approved  by  the  local  ethics
committee, and all individuals gave informed consent.
Bronchoalveolar lavage cells
BAL cells were obtained as described17, with minor
modification.  Two  50-ml  aliquots  of  saline  were
injected into the right middle lobe with immediate
aspiration with a plastic sterile syringe. After filtration
through a double layer of surgical gauze, total cells
were  counted  in  a  small  aliquot  using  a  hemocyt-
ometer. We count differential cells by identifying at
least 200  cells  on Diff-Quick  stained cytocentrifuge
preparations (Cytospine II; Shando Instruments, Run-
corn, UK). Alveolar macrophages (AMs) obtained via
BAL were resuspended in  RPMI  1640  medium  and
allowed  to  adhere  to  plastic  Petri  dishes  (Nunc,
Roskilde, Denmark) at 37°C, in a 5% CO2 atmosphere
for 1h. Thereafter, non-adherent cells were removed
by  gently  flooding  dishes  with  phosphate-buffered
saline, while adherent cells were detached by a 5min
exposure to 0.02% ethylenediamine tetraacetic acid.
Enriched  preparations  contained  >  95%  AMs.  Cell
viability  was  >  98%,  assessed  using  Tripan  blue
exclusion. Cytocentrifuge preparations of 0.1ml were
placed on slides and air-dried at room temperature
overnight. The slides were fixed in cold acetone for
5min at 4°C, wrapped in plastic film  and stored at
–20°C. 
Immunocytochemical staining
To detect ICAM-1, CD54 monoclonal antibodies were
used in conjunction with the alkaline phosphatase/
anti-alkaline phosphatase (APAAP) procedure. To eval-
uate the reaction, the slides were viewed under light
microscopy and 200 cells were counted in each area.
In vitro aggregation of AMs by cytokines
Human lung fibroblasts (CCL-153) obtained from the
American Type  Culture  Collection were cultured in
modified Ham’s F12 (Sigma, USA) supplemented with
10% fetal calf serum at 37°C and 5% CO2, then seeded
at  a  density  of  1.0 ´ 105 cells  in Tissue-Tek  slide-
s. AMs  were  suspended  in  chamber  slides  at  a
density  of  1 ´ 103/well.  Cells  were  cultured  with
medium alone, TNF-a or INF-g, and then incubated at
37°C for 24h in Tissue-Tek slides coated with CCL-153
cells.  Thereafter,  either  anti-ICAM-1,  anti-leukocyte
function associated antigen-1 (anti-LFA-1), anti-Mac-1
or isotype control antibody was added. After 24h of
culture, cells were fixed and stained. Aggregation was
measured by counting the number of aggregates of >
5 cells per 200 ´ field (agg/hpf).
Statistics
Statistical  significance  was  determined  using  Stu-
dent’s t-test and significance was determined at p <
0.05.
Results
Total and differential cell counts
The total number of cells recovered from the patient
with pulmonary sarcoidosis (1.42  ± 0.31 ´ 105/ml)
was increased compared with healthy controls (0.99
±  0.15 ´ 105/ml).  Furthermore,  the  percentage  of
lymphocytes was significantly increased in pulmonary
sarcoidosis compared  with  controls. The  CD4/CD8
ratio in BALF from patients with pulmonary sarcoido-
sis was 2.9 ± 0.5.
Immunocytological staining of AMs and human
lung fibroblasts
AMs  were  identified  according to  morphologic  cri-
teria, and red staining of the cell membrane recog-
nized positive cells. Data are expressed as positivity
(%) of total AMs. The percentages of AMs expressing
ICAM-1  in  control  and  patients  with  pulmonary
sarcoidosis are shown in  Fig.  1. The ratio of ICAM-
1-positive AMs  was  significantly  higher  in  patients
with pulmonary sarcoidosis than in controls. In both
groups, the percentage of ICAM-1-positive AMs trea-
ted  with TNF-a was significantly  higher than those
treated with medium alone. INF-g also stimulated AM
ICAM-1 expression in both groups.  Figure  2 shows
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FIG. 1. Regulation of ICAM-1 expression on AM by TNF-a.
AM  cultured  with  non-treated (h ),  medium  alone  ( )  or
TNF-a ( ). P < 0.05, compared with control.sarcoid  AMs  stained  with  anti-ICAM-1  monoclonal
antibody  (mAb). Human  lung  fibroblasts  cultured
with medium alone weakly expressed ICAM-1. TNF-a
stimulated ICAM-1 expression on human lung fibro-
blasts. Figure 3 shows human lung fibroblasts stained
with anti-ICAM-1mAb.
Aggregation of AMs in vitro
Incubation of AMs from the patients with pulmonary
sarcoidosis  for  24h  resulted  in  the  spontaneous
formation  of  large  cellular  aggregates  (Fig.  4A).  In
contrast,  AMs  obtained  from  control  individuals
formed  small  clumps  (Fig.  4B).  In  vitro exposure,
TNF-a or INF-g increased the numbers of aggregates
in AMs from the control (Figs. 5 and 6). The effects of
TNF-a and INF-g did not differ over a period of 24h.
However, aggregation significantly  increased in AMs
treated  with TNF-a compared  for  48h  with  INF-g.
Both  processes  were  significantly  inhibited  in AMs
pretreated  with  anti-ICAM-1mAb  or  anti-LFA-1mAb
(Figs.  5  and  6).  Antibody  type  (anti-ICAM-1mAb
versus anti-LFA-1mAb) had no significantly different
effects. Aggregation was not inhibited when AMs were
pretreated  with  anti-MAC-1mAb  or  anti-IgG1 mAb.
Heparin, which may act as an anti-inflammatory, also
inhibited  the  effects  of  TNF-a-induced  or  INF-
g-induced aggregation (Figs. 5 and 6). The inhibitory
effect of heparin was weaker than that of both anti-
ICAM-1mAb and anti-LFA-1mAb.
Discussion
Cell adhesion is an important event that plays a role in
cell-to-cell communication mediated by inflammatory
cytokines  and  adhesion  molecules.  Several  chronic
interstitial lung diseases, such as pulmonary sarcoido-
sis and interstitial pneumonia,  are characterized by
interstitial cellular infiltration or alveolitis, granuloma
and varying degrees of interstitial fibrosis.1–3,18 Per-
sistent upregulation of adhesion molecules and cyto-
kines could lead to chronic cell activation, inflamma-
tion, and pathology. Members of the integrin family,
such as ICAM-1 and LFA-1, seem to be critical to the
cell-to-cell  interaction  of  immune  cells,  including
AMs.19,20 These glycoproteins play roles not only in
cellular  adhesion, but  probably  also in  signal  trans-
duction.21 The results of the present study indicate
that several early events initiate and regulate in vitro
aggregation  formation.  High  levels  of  ICAM-1  were
expressed on AMs from the patient with pulmonary
sarcoidosis. Alveolar macrophages cultured with TNF-
a and INF-g expressed significantly more ICAM-1 than
those  cultured  with  medium  alone. These  findings
ICAM-1 and human alveolar macrophages
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FIG. 2. Immunocytochemical staining of ICAM-1 on alveolar
macrophages (AM) (A), and after treatment with TNF-a (B)
from  a  patient  with  sarcoidosis.  Staining  for  IgG1,  as  a
negative control (C), on AM treated with TNF-a (´ 100). Using
APAAP complex, ICAM-1 expression on AM from a patient
with sarcoidosis was demonstrated. Staining of AM from a
patient treated with TNF-a resulted in more intense coloring
of the cell surface than staining of control AM.
FIG. 3. APAAP stains for ICAM-1 on human fibroblasts treated
with medium alone (A) or TNF-a(B) (´ 100). Human fibroblasts
expressed ICAM-1, showing a weak diffuse positivity on their
surface. ICAM-1 expression on the surface of human fibro-
blasts increased after stimulation with TNF-a.showed  that TNF-a and  INF-g can  induce  ICAM-1
expression on AMs and may be correlated with ICAM-
1 expression on AMs from the patients with pulmo-
nary sarcoidosis. Levels of TNF-a in the BAL fluid were
measured  using  an  enzyme-linked  immunosorbent
assay.  The  concentration  of  TNF-a was  not  high
enough to activate AMs. In patients with pulmonary
sarcoidosis, AMs are primed to become more respon-
sive than usual. TNF-a might account for peripheral
blood monocyte recruitment to the alveolar spaces of
patients  with  pulmonary  sarcoidosis.  ICAM-1  is
expressed only at low levels in resting cells, but it is
strongly upregulated on activation by cytokines. TNF-
a may be one mediator of the regulation of ICAM-1
expression  on  AMs  in  pulmonary  sarcoidosis. In
chronic interstitial lung  disease, mast cells infiltrate
the parenchyma. The role  of  mast cells is not well
understood in  lung  fibrosis,  but  mast  cell  tryptase
stimulates the  synthesis  of  type  I collagen and  the
proliferation of lung  fibroblasts.22 Heparin,  a major
component  of  the  mast  cell  granule  matrix,  is  a
polyanionic  anticoagulant.  However,  both  heparin
and heparin-related complex have several other func-
tions, among which are inhibition of fibrin deposition
in the tissues, proliferation of  fibroblasts associated
with proteases including tryptase and chymase, and
the  regulation  of  T-cell  or  eosinophil  infiltration-
mediated  allergic  inflammation.12–15 More  recent
studies have demonstrated that heparin can modulate
the TNF-a-induced inflammatory response through a
CD11b-dependent  mechanism  and  interaction  with
matrix metalloproteinase 2.23–25 Our previous study
demonstrated that matrix metalloproteinase (MMP)-1
and  MMP-9  were  strongly  positive  in  human  lung
fibroblasts  and  retained  MMP-1  and  MMP-2/MMP-9
activity.26 We showed that heparin inhibited aggrega-
tion formation, but to a lesser extent than anti-ICAM-
1mAb or anti-LFA-1mAb.
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FIG. 4. Aggregation of AM from a patient with pulmonary
sarcoidosis, treated with TNF-a (A) or TNF-a anti-ICAM-1 (B)
(both ´ 50). Aggregation of AM was abolished by treatment
with antibody to ICAM-1. APAAP stains for ICAM-1 on AM
treated  with  TNF-a (C)  (´ 100).  ICAM-1  expression  was
indicated by strong positivity in the cytoplasm and on the
membrane of AM.
FIG. 5. Effect of TNF-a, TNF-a + Anti-ICAM-1Ab, TNF-a + Anti-
LFA-1Ab and heparin on AM aggregation in vitro. Data are
presented  as  the  mean  ±SEM  of  the  number  of  cells
comprising each aggregate.We found no evidence supporting the notion that
heparin  attenuates  the  role  of  cell  adhesion  mole-
cules. Although recent findings suggest that heparin
disrupts cell–collagen attachment, our results do not
show direct interaction of AMs but rather interaction
between AMs  and  fibroblasts. They  also  show  that
heparin and MMPs act together to induce conforma-
tional  change  of  the  affinity  sites  of  adhesion
molecules.
More studies are required to define the mechanism
of inhibitory effects of ICAM-1 and heparin, as well as
to  determine  their  suitability  as  therapeutic agents
with which to treat pulmonary fibrosis. 
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FIG. 6. Effect of INF-g, INF-g + Anti-ICAM-1Ab, INF-g + Anti-
LFA-1Ab and heparin on AM aggregation in vitro. Data are
presented  as  the  mean  ±SEM  of  the  number  of  cells
comprising each aggregate.